Revenue remains highly volatile with quarterly figures ranging from $0.4M to $16.7M, while operating expenses like the $21.3M SG&A reported in 2026Q1 continue to significantly outpace gross profit.
| Sales/Revenue | 26.93M | 23.85M | 4.14M | 433.03K | 0 | 0 |
| Revenue Growth % | 511.23% | 475.51% | 856.99% | - | - | - |
| Cost of Goods Sold | 22.18M | 20.44M | 2.54M | 294.06K | 0 | 19.38K |
| COGS % of Revenue | - | 85.72% | 61.41% | 67.91% | - | - |
| Gross Profit | 4.74M | 3.4M | 1.6M | 138.97K | 0 | -19.38K |
| Gross Margin % | 17.62% | 14.28% | 38.59% | 32.09% | - | - |
| Gross Profit Growth % | - | 112.95% | 1050.61% | - | 100% | - |
| Operating Expenses | 78.87M | 60.6M | 27.95M | 16.18M | 5.1M | 2.59M |
| OpEx % of Revenue | - | 254.08% | 674.54% | 3736.72% | - | - |
| Selling, General & Admin | 62.78M | 48.24M | 24.81M | 15.42M | 3.83M | 2.55M |
| SG&A % of Revenue | - | 202.26% | 598.79% | 3560.15% | - | - |
| Research & Development | 16.09M | 12.36M | 3.14M | 764.58K | 1.27M | 41.61K |
| R&D % of Revenue | - | 51.82% | 75.75% | 176.57% | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -74.13M | -57.19M | -26.35M | -16.04M | -5.1M | -2.61M |
| Operating Margin % | -275.28% | -239.8% | -635.96% | -3704.63% | - | - |
| Operating Income Growth % | - | -117.01% | -64.28% | -214.61% | -95.51% | - |
| EBITDA | -69.31M | -55.28M | -25.88M | -16M | -4.95M | -2.59M |
| EBITDA Margin % | -257.38% | -231.79% | -624.59% | -3695.98% | - | - |
| EBITDA Growth % | -147.75% | -113.57% | -61.72% | -223.64% | -91.03% | - |
| D&A (Non-Cash Add-back) | 4.82M | 1.91M | 471K | 37.43K | 0 | 19.38K |
| EBIT | -175.43M | -158.99M | -32.05M | -16.18M | -4.95M | -2.61M |
| Net Interest Income | 7.11M | 6.21M | 979.82K | -109.47K | 3.38K | 115 |
| Interest Income | 9.32M | 6.79M | 1.24M | 9.07K | 3.38K | 115 |
| Interest Expense | 2.22M | 575K | 258.87K | 118.55K | 0 | 0 |
| Other Income/Expense | -103.64M | -102.37M | -5.96M | -258.26K | 153.91K | 113 |
| Pretax Income | -177.77M | -159.56M | -32.31M | -16.3M | -4.95M | -2.61M |
| Pretax Margin % | -660.17% | -669.05% | -779.73% | -3764.27% | - | - |
| Income Tax | 321.72K | 282K | 111.45K | -6.13K | 0 | 0 |
| Effective Tax Rate % | -0.18% | -0.18% | -0.34% | 0.04% | 0% | 0% |
| Net Income | -173.52M | -175.09M | -32.33M | -16.29M | -4.95M | -2.61M |
| Net Margin % | -644.41% | -734.17% | -780.26% | -3761.03% | - | - |
| Net Income Growth % | -412.9% | -441.51% | -98.54% | -229.34% | -89.62% | - |
| Net Income (Continuing) | -178.09M | -159.84M | -32.42M | -16.29M | -4.95M | -2.61M |
| Discontinued Operations | 1000K | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 10.02M | 58.75M | 3.27M | 2.53M | 0 | 0 |
| EPS (Diluted) | -1.43 | -2.11 | -0.63 | -0.49 | -0.13 | -0.08 |
| EPS Growth % | -224.5% | -234.92% | -28.57% | -276.92% | -71.28% | - |
| EPS (Basic) | - | -2.11 | -0.63 | -0.49 | -0.13 | -0.08 |
| Diluted Shares Outstanding | 121M | 83.01M | 55.67M | 33.07M | 35.91M | 34.36M |
| Basic Shares Outstanding | 121M | 83.01M | 55.67M | 33.07M | 35.91M | 34.36M |
| Dividend Payout Ratio | - | - | - | - | - | - |
Commercialization and Scale-up Execution
As reported in recent financial statements, ASPI's revenue trajectory remains highly inconsistent, with quarterly figures fluctuating between $0.4M and $16.7M, suggesting that the business is currently reliant on lumpy, project-based milestones rather than a predictable, recurring stream of isotope supply contracts or industrial offtake agreements.
The significant revenue spike observed in 2025Q4 appears to be an outlier that does not yet reflect a sustainable growth trend. Investors should monitor whether the company can transition from these sporadic project-based inflows to long-term, volume-driven supply agreements to validate the scalability of the ASP technology.
Based on the company's reported figures, gross margins have exhibited extreme volatility, ranging from a high of 100% in 2023Q4 to a low of 8.7% in 2025Q3, indicating that the firm has not yet achieved the production consistency required for stable industrial-scale profitability.
This margin compression suggests that the company is struggling to optimize its enrichment yields while managing the high fixed costs inherent in its specialized hardware. Until the firm can demonstrate a consistent, positive spread between production costs and market pricing, the current margin profile will likely remain a significant drag on overall financial performance.
According to recent SEC filings, ASPI's operating expenses, particularly SG&A, have consistently dwarfed gross profit, with SG&A reaching $21.3M in 2026Q1 alone, which highlights a cost structure that is currently misaligned with the company's early-stage commercial revenue generation capabilities.
The aggressive spending on R&D and administrative overhead suggests a management team prioritizing rapid infrastructure build-out over immediate bottom-line discipline. This high-burn environment warrants further investigation into the timeline for facility commissioning, as any delays will likely exacerbate the existing operating margin deficit.
As indicated by the financial data, the company's net losses are frequently exacerbated by significant stock-based compensation charges, which totaled $4.4M in 2026Q1, effectively masking the true underlying cash burn and creating a disconnect between reported EPS and actual operational performance.
The reliance on equity-based incentives to manage cash outflows may provide short-term liquidity relief but creates a persistent overhang for existing shareholders. Analysts should focus on the cash-basis burn rate rather than headline net income, as the latter is heavily influenced by non-cash accounting adjustments and volatile non-operating items.
Quick answers to the most common questions about buying ASPI stock.
For fiscal year 2025, ASP Isotopes Inc. Common Stock (ASPI) reported total revenue of $23.8M.
ASP Isotopes Inc. Common Stock (ASPI) reported a net loss of $175.1M for the fiscal year ending 2025.
ASP Isotopes Inc. Common Stock (ASPI) reported an operating income of $-57.2M, resulting in an operating profit margin of -239.8%. This margin reflects the operational efficiency of the business before interest and taxes.
ASP Isotopes Inc. Common Stock (ASPI) generated $3.4M in gross profit for the year, representing a gross profit margin of 14.3%. This demonstrates the company's core pricing power and production efficiency.